Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy
Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy : A Randomized Controlled Open Labeled Trial
Seoul National University Hospital
172 participants
Nov 27, 2022
INTERVENTIONAL
Conditions
Summary
This study aims to compare the efficacy and satisfaction of blood glucose management between continuous glucose monitoring versus traditional self blood glucose measurement in diabetic patients after pancreatectomy.
Eligibility
Inclusion Criteria4
- Patients over 19 years of age
- Preoperative diabetes history
- Patients who underwent subtotal or total pancreatectomy
- Patients who were diagnosed with diabetes mellitus in the evaluation of endocrine function test on the 7th day after pancreaticoduodenectomy, central pancreatectomy, or distal pancreatectomy
Exclusion Criteria5
- Patients who have used continuous blood glucose measurement device more than once before.
- Elderly patients who are not accustomed to using the smartphone applications
- Serious systemic diseases that can affect diabetes (chronic kidney disease, heart failure, decompensated liver cirrhosis, etc.)
- Steroid user during the study period
- Major medical or psychiatric condition that will affect response to treatment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
continuous glucose monitoring device
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05149625